HERTFORDSHIRE, England and
PITTSBURGH, Oct. 4, 2017 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) today announced that it is working to provide
aid to those affected by Hurricanes Harvey, Irma and Maria in
Florida, Puerto Rico and Texas. To date, the company has shipped more
than 6 million doses of medicine, including anti-infective,
cardiovascular, endocrine and metabolic, gastrointestinal,
hematological and respiratory medications, to aid in
hurricane-recovery efforts through its charitable distribution
partners, Direct Relief, Americares and Heart to Heart
International.
In addition, over the past weekend, Mylan chartered a cargo
aircraft to Puerto Rico carrying
more than 36,000 pounds of essential items needed by local
residents and Mylan employees. In Caguas, Puerto Rico, Mylan has opened the doors of its
manufacturing plant to Mylan employees and those in the surrounding
community to provide food, water and other assistance from the
site, in close coordination with local authorities. The Mylan team
continues to work around the clock to return the site to full
operation and is working closely with the U.S. Food and Drug
Administration to help address drug-shortage concerns.
Additionally, the company is working with the Federal Emergency
Management Agency to determine essential medicine needs, including
antibiotics, for the residents of Puerto
Rico.
In Texas, Mylan has partnered
with SBP, a nonprofit organization dedicated to national
disaster recovery, and has donated more than $80,000 to assist statewide efforts. This
monetary donation was made possible through generous employee
contributions and Mylan's corporate match.
In all affected areas, Mylan is offering housing and providing
direct financial assistance for Mylan employees in need.
Mylan CEO Heather Bresch
commented, "Like so many others, we have been saddened to learn
about the impact of the recent natural disasters in the U.S. and
beyond. Our top priorities remain focused on ensuring the safety of
our fellow employees and restoring our operations to meet patient
needs. We recognize that the rebuilding process will take a long
time in all three areas. We continue to evaluate how best to make
the greatest positive impact on our Mylan family as well as on the
surrounding communities in which we operate. For now, we keep those
affected in our thoughts and prayers, and we are proud of the
support that our Mylan colleagues, their families and nearby
communities have already provided to date."
About Mylan
Mylan is a global pharmaceutical company
committed to setting new standards in healthcare. Working together
around the world to provide 7 billion people access to high quality
medicine, we innovate to satisfy unmet needs; make reliability and
service excellence a habit; do what's right, not what's easy; and
impact the future through passionate global leadership. We offer a
growing portfolio of more than 7,500 marketed products around the
world, including antiretroviral therapies on which approximately
50% of people being treated for HIV/AIDS in the developing world
depend. We market our products in more than 165 countries and
territories. We are one of the world's largest producers of active
pharmaceutical ingredients. Every member of our more than
35,000-strong workforce is dedicated to creating better health for
a better world, one person at a time. Learn more at Mylan.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/mylan-provides-support-for-us-disaster-relief-efforts-300530716.html
SOURCE Mylan N.V.